Nitroglycerin and Maculopathy - a phase IV clinical study of FDA data

Summary:

Maculopathy is reported as a side effect among people who take Nitroglycerin (nitroglycerin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Elmiron, and have Cystitis interstitial.

The phase IV clinical study analyzes which people have Maculopathy when taking Nitroglycerin. It is created by eHealthMe based on reports of 52,631 people who have side effects when taking Nitroglycerin from the FDA, and is updated regularly.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

What is Maculopathy?

Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest) is found to be associated with 379 drugs and 730 conditions by eHealthMe. Check the latest studies of Maculopathy.

On Aug, 05, 2026

52,631 people reported to have side effects when taking Nitroglycerin.
Among them, 16 people (0.03%) have Maculopathy.

Among these 16 people:

How long have people been on Nitroglycerin when they have Maculopathy? *

What is the gender of people who have Maculopathy when taking Nitroglycerin? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Maculopathy when taking Nitroglycerin? *

What are other drugs people take besides Nitroglycerin? *

What are other side effects people have besides Maculopathy? *

Blindness: 6 people, 37.50%
Pain: 6 people, 37.50%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 5 people, 31.25%
Headache (pain in head): 5 people, 31.25%
Age-Related Macular Degeneration: 5 people, 31.25%
Cataract (clouding of the lens inside the eye): 5 people, 31.25%
Dizziness: 5 people, 31.25%
Tardive Dyskinesia (a disorder that involves involuntary movements): 5 people, 31.25%
Swallowing Difficulty: 5 people, 31.25%
Spinal Osteoarthritis (joint cartilage loss in spine): 5 people, 31.25%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 43.75%
Cystitis Interstitial (unknown cause characterized by bladder pain): 7 people, 43.75%
High Blood Pressure: 4 people, 25.00%
Stress And Anxiety: 4 people, 25.00%
Anal Fissure: 3 people, 18.75%
Fungal Infection: 3 people, 18.75%
Depression: 3 people, 18.75%
Multiple Allergies (allergy to multiple agents): 3 people, 18.75%
Electrolyte Imbalance: 2 people, 12.50%
Nausea (feeling of having an urge to vomit): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Nitroglycerin and have Maculopathy?

- Check whether Maculopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitroglycerin:

Nitroglycerin (52,884 reports)

Maculopathy treatments and more:

Maculopathy (5,625 reports)

Browse all side effects of Nitroglycerin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Maculopathy:

Maculopathy (379 drugs)

Browse all the conditions that are associated with Maculopathy:

Maculopathy (730 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitroglycerin) and Nitroglycerin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.